Bharat Forge: Update on litigation
Bharat Forge (BHARATFORG) filed a disclosure titled "Update on litigation". The company is valued at about ₹90,003 crore.
What happened
Bharat Forge (BHARATFORG) filed a disclosure with the exchanges on 7 October 2026 at 05:05 PM titled "Update on litigation".
Company snapshot
Bharat Forge is a mid-cap company in the Automobile and Auto Components sector, with a market value of about ₹90,003 crore.
The stock last traded at ₹1,841.8, against a 52-week range of ₹1,179.4–₹2,295 (19.8% below the high).
Before this filing the shares had moved −7.5% over the month and −13.2% over three months. Average daily turnover over the last 20 sessions was about ₹164 crore.
Promoters held 43.12% at the end of Q2 FY27, down 0.95% points from the previous quarter. Foreign institutions owned 15.19% and domestic institutions 32.86%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 3,909 | 283.7 | 5.93 |
| Q2 FY26 | 4,032 | 299.2 | 6.26 |
| Q3 FY26 | 4,343 | 264.2 | 5.53 |
| Q4 FY26 | 4,528 | 232.6 | 4.86 |
| Q1 FY27 | 4,640 | -89.7 | -1.88 |
What history shows
BCEIE has no earlier litigation filing from this company on record since May 2026.
Market-wide, 548 litigation filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 36% rising.
Past reactions describe what happened before; they are not a forecast.
In the news
Recent coverage elsewhere (links open the original publisher):
- BHARATFORG Outlook for the Week
- Bharat Forge secures contract from Pratt & Whitney Canada for aerospace engine components
- Bharat Forge Signs Long-Term Pratt & Whitney Canada Aerospace Deal for Engine Parts
- Shardul Amarchand Mangaldas & Co. advises Kotak Mahindra Capital, Morgan Stanley India and Nomura on ₹2,000 crore Qualified Institutions Placement by Bharat Forge Ltd.
- Bharat Forge Ltd. Key Financial Ratios – Valuation, Profitability & More
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.